Clinical Trials Insight: 700033676
Phase of Trial: Phase II
Latest Information Update: 19 May 2008
At a glance
- Drugs INGAP peptide; Lisofylline
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors DiaKine Therapeutics; Kinexum Metabolics
- 19 May 2008 New trial record.
- 07 May 2008 The planned initiation date is late 2008, according to a media release from DiaKine Therapeutics and Kinexum Metabolics.